We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

100 hedge funds and large institutions have $795M invested in Wave Life Sciences in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 48 increasing their positions, 20 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 20

60% more call options, than puts

Call options by funds: $5.24M | Put options by funds: $3.27M

2.92% more ownership

Funds ownership: 85.99% → 88.91% (+2.9%)

9% less funds holding

Funds holding: 110 → 100 (-10)

26% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 27

30% less capital invested

Capital invested by funds: $1.14B → $795M (-$347M)

67% less funds holding in top 10

Funds holding in top 10: 6 → 2 (-4)

Holders
100
Holders Change
-10
Holders Change %
-9.09%
% of All Funds
2.17%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.04%
New
20
Increased
48
Reduced
20
Closed
27
Calls
$5.24M
Puts
$3.27M
Net Calls
+$1.98M
Net Calls Change
+$5.55M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$69.7M
2
BG
Bellevue Group
Switzerland
+$42.5M
3
Goldman Sachs
Goldman Sachs
New York
+$13.9M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$13.2M
5
ACH
ArrowMark Colorado Holdings
Colorado
+$9.38M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$35.1M
2
RI
RTW Investments
New York
-$17M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.1M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$11.7M
5
AG
Artal Group
Luxembourg
-$9.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
PHS
101
PFM Health Sciences
California
– -$35.1M -902,578 Closed
RI
102
RTW Investments
New York
– -$17M -436,777 Closed
AG
103
Artal Group
Luxembourg
– -$9.71M -250,000 Closed
MWNA
104
Marshall Wace North America
New York
– -$8.56M -220,321 Closed
EAM
105
Eventide Asset Management
Massachusetts
– -$6.62M -170,400 Closed
IBT
106
International Biotechnology Trust
United Kingdom
– -$5.63M -145,000 Closed
SSA
107
Schonfeld Strategic Advisors
New York
– -$2.6M -67,000 Closed
Marshall Wace
108
Marshall Wace
United Kingdom
– -$2.32M -59,629 Closed
Norges Bank
109
Norges Bank
Norway
– -$1.94M -50,000 Closed
MCM
110
Moore Capital Management
New York
– -$1.42M -36,600 Closed
TCS
111
Texas Children's
Texas
– -$1.19M -30,546 Closed
Invesco
112
Invesco
Georgia
– -$813K -20,914 Closed
HI
113
HBK Investments
Texas
– -$486K -12,509 Closed
OPPM
114
Opus Point Partners Management
New York
– -$377K -9,716 Closed
HCMT
115
Highland Capital Management (Texas)
Texas
– -$311K -8,000 Closed
NIT
116
NumerixS Investment Technologies
British Columbia, Canada
– -$288K -7,600 Closed
PIM
117
Partner Investment Management
California
– -$287K -7,383 Closed
Los Angeles Capital Management
118
Los Angeles Capital Management
California
– -$246K -6,330 Closed
FAM
119
Fred Alger Management
New York
– -$233K -6,000 Closed
TI
120
Trexquant Investment
Connecticut
– -$200K -5,145 Closed
SG Americas Securities
121
SG Americas Securities
New York
– -$140K -3,602 Closed
SO
122
STRS Ohio
Ohio
– -$108K -2,800 Closed
PHK
123
Point72 Hong Kong
Hong Kong
– -$46K -1,173 Closed
MAM
124
Meeder Asset Management
Ohio
– -$12K -301 Closed
Twin Tree Management
125
Twin Tree Management
Texas
– -$8K -199 Closed
2 3 4
5
6

WVE Hedge Fund Activity: Q2 2019 in Review

100 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2019, worth a combined $795M — down 30% from $1.14B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of WVE and 20 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 48 added.

The largest buyer was Wellington Management Group, adding an estimated $69.7M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $35.1M sold.

  • 100 institutional investors held Wave Life Sciences (WVE) as of Q2 2019, down from 110 in Q1 2019.
  • Funds reported $795M of Wave Life Sciences stock for Q2 2019, down 30% quarter-over-quarter.
  • 20 funds opened new Wave Life Sciences positions in Q2 2019 and 27 closed out, a net change of -7 holders.
  • The largest Wave Life Sciences buyer in Q2 2019 was Wellington Management Group, an estimated $69.7M added.
  • The largest Wave Life Sciences seller in Q2 2019 was PFM Health Sciences, an estimated $35.1M sold.

Based on aggregated 13F filings for Q2 2019.